Journal of Tuberculosis and Lung Disease ›› 2021, Vol. 2 ›› Issue (2): 169-173.doi: 10.3969/j.issn.2096-8493.2021.02.014
• Original Articles • Previous Articles Next Articles
LIU Xin-yu, ZHANG Qian, SUN Qian()
Received:
2021-04-22
Online:
2021-06-30
Published:
2021-07-01
Contact:
SUN Qian
E-mail:anas2008@163.com
LIU Xin-yu, ZHANG Qian, SUN Qian. Analysis of drug resistance of multidrug-resistant Mycobacterium tuberculosis to multiple drugs in Changping District of Beijing[J]. Journal of Tuberculosis and Lung Disease , 2021, 2(2): 169-173. doi: 10.3969/j.issn.2096-8493.2021.02.014
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.3969/j.issn.2096-8493.2021.02.014
药品 | MIC值 范围 (mg/L) | MIC值菌株分布(株) | 临界 浓度 (mg/L) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
≤0.015 mg/L | 0.03 mg/L | 0.06 mg/L | 0.12 mg/L | 0.25 mg/L | 0.5 mg/L | 1 mg/L | 2 mg/L | 4 mg/L | 8 mg/L | |||
Lfx | 0.12~8 | 0 | 0 | 0 | 16 | 22 | 2 | 9 | 10 | 20 | 4 | 1 |
Mfx | 0.06~4 | 0 | 0 | 18 | 14 | 6 | 11 | 9 | 15 | 10 | 0 | 0.5 |
Bdq | 0.015~2 | 62 | 10 | 5 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0.25 |
Cfz | 0.06~4 | 0 | 0 | 57 | 15 | 3 | 5 | 0 | 2 | 1 | 0 | 1 |
Lzd | 0.03~2 | 0 | 9 | 7 | 31 | 26 | 5 | 1 | 4 | 0 | 0 | 1 |
Dlm | 0.015~1 | 78 | 1 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0.125 |
药品 基因名称 | 引物序列(5'~3') | 片断长 度(bp) |
---|---|---|
Lfx/Mfx | ||
gyrA | 上游 TGACATCGAGCAGGAGATGC | 320 |
下游 GGGCTTCGGTGTACCTCATC | ||
gyrB | 上游 GTGGAAATATGTTGGCCGTC | 413 |
下游 GTCGTTGTGAACAACGCTGTG | ||
Lzd | ||
23S rRNA | 上游 GGTTGAAGACTGAGGGGATGAG | 2422 |
下游 CATCGGCGCTGGCAGGCTTAG | ||
rplC | 上游 GCTGCGGCTGGACGACTC | 420 |
下游 CTCTTGCGCAGCCATCACTTC | ||
rplD | 上游 CCGGGCGGATGGGCAATGACC | 936 |
下游 GGAATCCGGGCGCACCAAAAAC | ||
Bdq | ||
atpE | 上游 TGTACTTCAGCCAAGCGATGG | 454 |
下游 CCGTTGGGAATGAGGAAGTTG | ||
pepQ | 上游 ATCAATGCCCCCTGGAAC | 1371 |
下游 GCACGTTCTTCAACTTGGTG | ||
Cfz | ||
rv1979c | 上游 GCGGCGGAAATGAGTGT | 1647 |
下游 ATGCACGACGGCTTTATCA | ||
Bdq/Cfz | ||
rv0678 | 上游 TGCCTTCGGAACCAAAGAA | 795 |
下游 GACAACACGGTCACCTACAA | ||
Dlm | ||
fbiA | 上游 CGGTTCTGTTGTGGTTGGG | 1136 |
下游 CCGATGACGGGCAGGATC | ||
fbiB | 上游 GCCGCTGCTGATGACCGA | 1494 |
下游 TCGGGAGGTTGATGGTTGG | ||
fbiC | 上游 GTCCACCGCTCTGCCGAGTC | 2386 |
下游 GCCACCTTCGAGCATCACC | ||
fgd1 | 上游 TCGCGTTTATGGCATAGGAGT | 1090 |
下游 ACTTACCCGTCTGCGATTCTG | ||
ddn | 上游 CACCATCATCGAGCGGATTT | 765 |
下游 CAAGGGCGTGAAATGGGAT |
基因 碱基改变 | 氨基酸改变 | 药品 | 菌株数 | 突变率(%)a |
---|---|---|---|---|
gyrA | ||||
G262T | Gly88Cys | Lfx | 1 | 2.6(1/39) |
Mfx | 1 | 2.6(1/39) | ||
G265A | Asp89Asn | Lfx | 1 | 2.6(1/39) |
Mfx | 1 | 2.6(1/39) | ||
C269T | Ala90Val | Lfx | 8 | 20.5(8/39) |
Mfx | 6 | 15.4(6/39) | ||
T271C | Ser91Pro | Lfx | 1 | 2.6(1/39) |
Mfx | 1 | 2.6(1/39) | ||
G280T | Asp94Tyr | Lfx | 11 | 28.2(11/39) |
Mfx | 11 | 28.2(11/39) | ||
G280A | Asp94Asn | Lfx | 4 | 10.3(4/39) |
Mfx | 4 | 10.3(4/39) | ||
A281C | Asp94Ala | Lfx | 6 | 15.4(6/39) |
Mfx | 5 | 12.8(5/39) | ||
A281G | Asp94Gly | Lfx | 13 | 33.3(13/39) |
Mfx | 9 | 23.1(9/39) | ||
G284C | Ser95Thr | Lfx | 34 | 87.2(34/39) |
Mfx | 34 | 87.2(34/39) | ||
Rv0678 | ||||
A152G | Gln31Arg | Bdq | 1 | 1/2 |
Cfz | 1 | 1/3 | ||
T157C | Ser53Pro | Bdq | 1 | 1/2 |
Cfz | 1 | 1/3 | ||
rplC | ||||
T460C | Cys154Arg | Lzd | 2 | 2/4 |
ddn | ||||
G241A | Gly81Ser | Dlm | 2 | 2/4 |
fbiC | ||||
G952A | Val318Ile | Dlm | 1 | 1/4 |
[1] | World Health Organization. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). Geneva: World Health Organization, 2018. |
[2] | Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved standard. Wayne: Clinical and Laboratory Standards Institute, 2018. |
[3] |
Wang G, Jiang G, Jing W, et al. Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey. J Infect, 2021,82(3):371-377. doi: 10.1016/j.jinf.2021.02.004.
doi: 10.1016/j.jinf.2021.02.004 URL |
[4] |
Zhang Z, Li T, Qu G, et al. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates. Int J Antimicrob Agents, 2015,45(1):71-75. doi: 10.1016/j.ijantimicag.2014.09.012.
doi: 10.1016/j.ijantimicag.2014.09.012 URL |
[5] |
Schena E, Nedialkova L, Borroni E, et al. Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC MGIT 960 system. J Antimicrob Chemother, 2016,71(6):1532-1539. doi: 10.1093/jac/dkw044.
doi: 10.1093/jac/dkw044 URL |
[6] |
Huo F, Luo J, Shi J, et al. A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations. Antimicrob Agents Chemother, 2018,62(4):e02303-17. doi: 10.1128/AAC.02303-17.
doi: 10.1128/AAC.02303-17 |
[7] |
Che Y, Song Q, Yang T, et al. Fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis independent of fluoroquinolone use. Eur Respir J, 2017,50(6):1701633. doi: 10.1183/13993003.01633-2017.
doi: 10.1183/13993003.01633-2017 URL |
[8] |
Hameed HMA, Tan Y, Islam MM, et al. Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China. J Thorac Dis, 2019,11(11):4613-4625. doi: 10.21037/jtd.2019.11.03.
doi: 10.21037/jtd.2019.11.03 pmid: 31903250 |
[9] |
Zhu C, Zhang Y, Shen Y, et al. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China. Diagn Microbiol Infect Dis, 2012,73(3):260-263. doi: 10.1016/j.diagmicrobio.2012.03.025.
doi: 10.1016/j.diagmicrobio.2012.03.025 URL |
[10] |
Mokrousov I, Otten T, Manicheva O, et al. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob Agents Chemother, 2008,52(8):2937-2939. doi: 10.1128/AAC.00036-08.
doi: 10.1128/AAC.00036-08 URL |
[11] |
Chan RC, Hui M, Chan EW, et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother, 2007,59(5):866-873. doi: 10.1093/jac/dkm054.
doi: 10.1093/jac/dkm054 URL |
[12] |
Umubyeyi AN, Rigouts L, Shamputa IC, et al. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey. J Antimicrob Chemother, 2007,59(5):1031-1033. doi: 10.1093/jac/dkm038.
doi: 10.1093/jac/dkm038 URL |
[13] |
Andries K, Villellas C, Coeck N, et al. Acquired resistance of Mycobacterium tuberculosis to bedaquiline. PLoS One, 2014,9(7):e102135. doi: 10.1371/journal.pone.0102135.
doi: 10.1371/journal.pone.0102135 URL |
[14] |
孙晴, 黄海荣, 王桂荣. 贝达喹啉、氯法齐明和德拉马尼对常见致病性非结核分枝杆菌体外抑菌活性及耐药机制的研究进展. 中国防痨杂志, 2020,42(8):880-884. doi: 10.3969/j.issn.1000-6621.2020.08.019.
doi: 10.3969/j.issn.1000-6621.2020.08.019 |
[15] |
Beckert P, Hillemann D, Kohl TA, et al. rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains. Antimicrob Agents Chemother, 2012,56(5):2743-2745. doi: 10.1128/AAC.06227-11.
doi: 10.1128/AAC.06227-11 URL |
[16] |
Liu Y, Matsumoto M, Ishida H, et al. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB). Tuberculosis (Edinb), 2018,111:20-30. doi: 10.1016/j.tube.2018.04.008.
doi: 10.1016/j.tube.2018.04.008 URL |
[17] |
Fujiwara M, Kawasaki M, Hariguchi N, et al. Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis. Tuberculosis (Edinb), 2018,108:186-194. doi: 10.1016/j.tube.2017.12.006.
doi: S1472-9792(17)30271-8 pmid: 29523322 |
[1] | ZHOU Bi-xia, YUAN Gong-ling, ZENG Ling-wu, ZHU Yi, CHENG Xi, LI Min, WU Mei-ying. Comparative analysis of CT signs of Mycobacterium kansasii pulmonary disease and pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 125-130. |
[2] | ZHANG Zhi-guo, GUO Hai-ping, PANG Yu. Considerations for the application of laboratory diagnostics in detecting drug-resistant tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(1): 13-17. |
[3] | YANG Yang, LU Shui-hua. Adult-onset mendelian susceptibility to mycobacterial disease: a case report and literature review [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 226-232. |
[4] | YI Jun-li, YANG Xin-yu, ZHANG Jie, TIAN Li-li, DING Bei-chuan, WU Wen-qing. Application evaluation of three methods for identification between Mycobacterium tuberculosis complex and non-tuberculous mycobacteria [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 240-244. |
[5] | DAI Zhi-song, LIN Shu-fang, WEI Shu-zhen, ZHOU Yin-fa. Analysis of epidemiological characteristics of pulmonary tuberculosis in Fujian Province from 2011 to 2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 249-255. |
[6] | WANG Mei-hua, ZHANG Wen-qian, JING Rui, ZHANG Guang-li. Analysis of epidemiological characteristics of pulmonary tuberculosis in Ji’nan from 2010 to 2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(3): 262-264. |
[7] | REN Zhen-juan, ZHANG Hai-jie, SU Yun-kai, MA Yan, LIU Yao. Correlation between amikacin resistance and rrs gene mutation in multidrug-resistant Mycobacterium tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 117-120. |
[8] | TANG Gui-hua, SUN Qian, WANG Xiao-fan, XIAN Hai-bin, ZHANG Qian, YANG Xiao-wei, WANG Li. The value of GeneXpert MTB/RIF technology in tuberculosis detection and resistance to rifampin [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 121-125. |
[9] | XIONG Li-fen, LAI Ming-yue, YANG Qian-ru, FAN Jian-hua, YAN Wan-ming, GUO Li-zhu.. Analysis of the epidemiologic feature of pulmonary tuberculosis in Xishuangbanna,2005—2018 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 165-169. |
[10] | FENG Feng, TANG Feng-zhen, YAO Ming-mei, CHENG Lu, DU Li-jun. Application progress of proteome in research of the Mycobacterium tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 174-178. |
[11] | ZHONG Chong-xia, WANG Hua-shan. Analysis on reporting and referral quality of pulmonary tuberculosis cases by general hospitals above level Ⅱ in Shuyang County,Jiangsu Province during 2018—2019 [J]. Journal of Tuberculosis and Lung Disease, 2020, 1(2): 179-182. |
[12] | LIU Di. Virus genome, the direct way to know the SARS-CoV-2 virus [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 16-18. |
[13] | TANG Zai-qing, TANG Ming-hao, ZHU Xiao-lin, LIU Yu-qin. Application value of gene chip technology in the rapid diagnosis of tuberculosis and the identification of mycobacterium [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 55-57. |
[14] | JING Rui, WANG Mei-hua, CAI Jun-li, ZHANG Wen-qian, REN Wen. Analysis of screening results of close contacts of tuberculosis patients in schools in Ji’nan in 2018 [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 64-67. |
[15] | JIANG Jing, SUN De-bin, LIU Jia-qi, WANG Liang, GAO Jing-jing, HAN Song, ZHANG Ying. Analysis of visit delay and its risk factors among 205 hospitalized tuberculosis patients in Shenyang [J]. Journal of Tuberculosis and Lung Health, 2020, 9(1): 72-78. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||